Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Pausch

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
European Journal of Pharmacology|October 24, 2006
Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonistJulia N Heinrich, Julie Brennan, Margaret H Lai, et al.
European Journal of Pharmacology|January 27, 2009
Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonistsJulia N Heinrich, John A Butera, Tikva Carrick, et al.
Brain Research|May 2, 2006
Characterization of Gpr101 expression and G-protein coupling selectivityBrian Bates, Lynn Zhang, Stan Nawoschik, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophreniaYinfa Yan, Ping Zhou, David P Rotella, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2015
Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development propertiesScott D Kuduk, Jason W Skudlarek, Christina N DiMarco, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2008
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activitiesFeng Liu, Steve Grauer, Cody Kelley, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2009
WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activityJulie A Brennan, Radka Graf, Steven M Grauer, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2009
Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophreniaDavid P Rotella, Geraldine R McFarlane, Alexander Greenfield, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Pharmacology|October 24, 2006
Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonistJulia N Heinrich, Julie Brennan, Margaret H Lai, et al.
European Journal of Pharmacology|January 27, 2009
Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonistsJulia N Heinrich, John A Butera, Tikva Carrick, et al.
Brain Research|May 2, 2006
Characterization of Gpr101 expression and G-protein coupling selectivityBrian Bates, Lynn Zhang, Stan Nawoschik, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophreniaYinfa Yan, Ping Zhou, David P Rotella, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2015
Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development propertiesScott D Kuduk, Jason W Skudlarek, Christina N DiMarco, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2008
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activitiesFeng Liu, Steve Grauer, Cody Kelley, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2009
WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activityJulie A Brennan, Radka Graf, Steven M Grauer, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2009
Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophreniaDavid P Rotella, Geraldine R McFarlane, Alexander Greenfield, et al.
Pageof 2